Woodrow, This time you hit it right on the money. I agree and would love for CYGX to explain just what is going on to the shareholders before they have to explain it to the judge in the PP court case.
CytoGenix Inc. Licenses Anti-Herpes DNA Formulation for Manufacture and Distribution in the People's Republic of China
Houston, TX, (July 16, 2003) Cytogenix, Inc. (OTCBB: CYGX)
CytoGenix, announced today, that it has granted an option for an exclusive license to Phanuel Pursuits, Ltd., an international trading company, for manufacture and distribution of its proprietary anti-herpes topical cream in the People’s Republic of China. The compound is effective in combating both genital and labial herpes (cold sores). HOW IS IT EFFECTIVE IF TWO YEARS LATER TESTING ON PIGS??
Arnold
"If the facts don't fit the theory, change the facts."